14-3-3 Proteins - A focus on cancer and human disease

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 3, 2004, Pages 633-642

  Wilker, Erik ^a   Yaffe, Michael B ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

14 3 3 Proteins; Cancer; Human disease; Modular signaling domains; Phosphoserine threonine

Indexed keywords

DOXORUBICIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOSERINE; PHOSPHOTHREONINE; PROTEIN 14 3 3; PROTEIN KINASE; PROTEIN SUBUNIT; PROTEIN TYROSINE PHOSPHATASE; RAF PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER; CELL CYCLE; CRYSTAL STRUCTURE; CYTOSKELETON; DEGENERATIVE DISEASE; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVATION; EUKARYOTIC CELL; GENE TARGETING; HEART FUNCTION; HUMAN; LIGAND BINDING; LIVER CELL CARCINOMA; LUNG CARCINOMA; MITOSIS; MOUTH CARCINOMA; MUTATION; NEOPLASM; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STRUCTURE ANALYSIS; UPREGULATION;

14-3-3 PROTEINS; APOPTOSIS; CDC25 PHOSPHATASE; CELL CYCLE; CELL CYCLE PROTEINS; DNA; DNA DAMAGE; HUMANS; INTEGRINS; MAP KINASE SIGNALING SYSTEM; NEOPLASMS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RAF KINASES;

EUKARYOTA;

EID: 4444358273     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.04.015     Document Type: Review

References (140)

1. Moore B., and Vj P. Specific acidic proteins of the nervous system Fd C. Physiological and biochemical aspects of nervous integration 1967 Prentice-Hall Englewood Cliffs 343 359
2. Muslin A.J. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine Cell 84 6 1996 889 897
3. Morrison D.K. Identification of the major phosphorylation sites of the Raf-1 kinase J Biol Chem 268 23 1993 17309 17316
4. Yaffe M.B. Phosphotyrosine-binding domains in signal transduction Nat Rev Mol Cell Biol 3 3 2002 177 186
5. Pawson T., and Schlessinger J. SH2 and SH3 domains Curr Biol 3 7 1993 434 442
6. Kuriyan J., and Cowburn D. Modular peptide recognition domains in eukaryotic signaling Annu Rev Biophys Biomol Struct 26 1997 259 288
7. Yaffe M.B., and Elia A.E. Phosphoserine/threonine-binding domains Curr Opin Cell Biol 13 2 2001 131 138
8. Bell D.W. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome Science 286 5449 1999 2528 2531
9. Moberg K.H. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines Nature 413 6853 2001 311 316
10. Spruck C.H. CDC4 gene mutations in endometrial cancer Cancer Res 62 16 2002 4535 4539
11. Strohmaier H. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line Nature 413 6853 2001 316 322
12. Wulf G.M. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1 EMBO J 20 13 2001 3459 3472
13. Ryo A. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells Mol Cell Biol 22 15 2002 5281 5295
14. Suzuki H. Inactivation of the 14-3-3sigma gene is associated with 5 CpG island hypermethylation in human cancers Cancer Res 60 16 2000 4353 4357
15. Ferguson A.T. High frequency of hypermethylation at the 14-3-3sigma locus leads to gene silencing in breast cancer Proc Natl Acad Sci USA 97 11 2000 6049 6054
16. Urano T. Efp targets 14-3-3sigma for proteolysis and promotes breast tumour growth Nature 417 6891 2002 871 875
17. Aitken A. 14-3-3 Proteins: biological function and domain structure Biochem Soc Trans 23 3 1995 605 611
18. Fu H., Subramanian R.R., and Masters S.C. 14-3-3 Proteins: structure, function, and regulation Ann Rev Pharmacol Toxicol 40 2000 617 647
19. Tzivion G., Shen Y.H., and Zhu J. 14-3-3 Proteins; bringing new definitions to scaffolding Oncogene 20 44 2001 6331 6338
20. Chung H.J., Sehnke P.C., and Ferl R.J. The 14-3-3 proteins: cellular regulators of plant metabolism Trends Plant Sci 4 9 1999 367 371
21. Yaffe M.B. The structural basis for 14-3-3: phosphopeptide binding specificity Cell 91 7 1997 961 971
22. Pozuelo Rubio M. 14-3-3-Affinity purification of over 200human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation, and trafficking Biochem J 379 Pt 2 2004 395 408
23. Liu D. Crystal structure of the zeta isoform of the 14-3-3 protein Nature 376 6536 1995 191 194
24. Xiao B. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways Nature 376 6536 1995 188 191
25. Wang W., and Shakes D.C. Molecular evolution of the 14-3-3 protein family J Mol Evol 43 4 1996 384 398
26. Yaffe M.B. How do 14-3-3 proteins work?Gatekeeper phosphorylation and the molecular anvil hypothesis FEBS Lett 513 1 2002 53 57
27. Aitken A. 14-3-3Alpha and delta are the phosphorylated forms of Raf-activating 14-3-3beta and zeta. In vivo stoichiometric phosphorylation in brain at a Ser-Pro-Glu-Lys MOTIF J Biol Chem 270 11 1995 5706 5709
28. Dubois T. 14-3-3 is phosphorylated by casein kinase 1on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction J Biol Chem 272 46 1997 28882 28888
29. Megidish T. A novel sphingosine-dependent protein kinase (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein J Biol Chem 273 34 1998 21834 21845
30. Powell D.W. Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2substrate: role in dimer formation and ligand binding Mol Cell Biol 23 15 2003 5376 5387
31. Megidish T. The signal modulator protein 14-3-3 is a target of sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells Biochem Biophys Res Commun 216 3 1995 739 747
32. Obsilova V. 14-3-3Zeta C-terminal stretch changes its conformation upon ligand binding and phosphorylation at Thr232 J Biol Chem 279 6 2004 4531 4540
33. Shen Y.H. Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding Mol Biol Cell 14 11 2003 4721 4733 [Epub 2003 Aug 7]
34. Aitken A. Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants Plant Mol Biol 50 6 2002 993 1010
35. Tzivion G., Luo Z., and Avruch J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity Nature 394 6688 1998 88 92
36. Obsil T. Crystal structure of the 14-3-3zeta:serotonin N-acetyltransferase complex. A role for scaffolding in enzyme regulation Cell 105 2 2001 257 267
37. Capasso H. Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest J Cell Sci 115 Pt 23 2002 4555 4564
38. Wang Y. Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2/M cell population Cell Growth Differ 11 4 2000 211 219
39. Lee J., Kumagai A., and Dunphy W.G. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins Mol Biol Cell 12 3 2001 551 563
40. Rothblum-Oviatt C.J., Ryan C.E., and Piwnica-Worms H. 14-3-3-Binding regulates catalytic activity of human Wee1 kinase Cell Growth Differ 12 12 2001 581 589
41. Peng C.Y. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 Science 277 5331 1997 1501 1505 [see comments]
42. Toyo-Oka K. 14-3-3Epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for MillerDieker syndrome Nat Genet 34 3 2003 274 285
43. Datta S.R. 14-3-3 Proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation Mol Cell 6 1 2000 41 51
44. Muslin A.J., and Xing H. 14-3-3 Proteins: regulation of subcellular localization by molecular interference Cell Signal 12 1112 2000 703 709
45. Vercoutter-Edouart A.S. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells Cancer Res 61 1 2001 76 80
46. Umbricht C.B. Hypermethylation of 14-3-3sigma (stratifin) is an early event in breast cancer Oncogene 20 26 2001 3348 3353
47. Moreira J.M., Gromov P., and Celis J.E. Expression of the tumor suppressor protein 14-3-3sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial to mesenchymal transition Mol Cell Proteomics 21 2004 21
48. Iwata N. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3sigma gene in human hepatocellular carcinoma Oncogene 19 46 2000 5298 5302
49. Suzuki H. Inactivation of the 14-3-3sigma gene is associated with 5 CpG island hypermethylation in human cancers Cancer Res 60 16 2000 4353 4357
50. Villaret D.B. Identification of genes overexpressed in head-and-neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis Laryngoscope 110 3Pt 1 2000 374 381
51. Gasco M. Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia Oncogene 21 12 2002 1876 1881
52. Hermeking H. 14-3-3Sigma is a p53-regulated inhibitor of G2/M progression Mol Cell 1 1 1997 3 11
53. Chan T.A. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage Nature 401 6753 1999 616 620
54. Laronga C. Association of the cyclin-dependent kinases and 14-3-3sigma negatively regulates cell cycle progression J Biol Chem 275 30 2000 23106 23112
55. Stavridi E.S. Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest Cancer Res 61 19 2001 7030 7033
56. Waterman M.J. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins Nat Genet 19 2 1998 175 178
57. Yang H.Y. 14-3-3Sigma positively regulates p53 and suppresses tumor growth Mol Cell Biol 23 20 2003 7096 7107
58. Melino G. Functional regulation of p73 and p63: development and cancer Trends Biochem Sci 28 12 2003 663 670
59. Westfall M.D. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations Mol Cell Biol 23 7 2003 2264 2276
60. Weber H.O. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways Oncogene 21 20 2002 3207 3212
61. De Laurenzi V. p63 and p73 transactivate differentiation gene promoters in human keratinocytes Biochem Biophys Res Commun 273 1 2000 342 346
62. Bunz F. Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 282 5393 1998 1497 1501
63. Clark G.J. 14-3-3Zeta negatively regulates Raf-1 activity by interactions with the Raf-1 cysteine-rich domain J Biol Chem 272 34 1997 20990 20993
64. Takihara Y., Matsuda Y., and Hara J. Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation Carcinogenesis 21 11 2000 2073 2077
65. Sugiyama A. Forced expression of antisense 14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo Carcinogenesis 24 9 2003 1549 1559
66. Davies H. Mutations of the BRAF gene in human cancer Nature 417 6892 2002 949 954
67. MacNicol M.C., Muslin A.J., and MacNicol A.M. Disruption of the 14-3-3-binding site within the B-Raf kinase domain uncouples catalytic activity from PC12 cell differentiation J Biol Chem 275 6 2000 3803 3809
68. Papin C. Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system Oncogene 12 10 1996 2213 2221
69. Berruti G. A novel rap1/B-Raf/14-3-3theta protein complex is formed in vivo during the morphogenetic differentiation of postmeiotic male germ cells Exp Cell Res 257 1 2000 172 179
70. Qiu W. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins J Biol Chem 275 41 2000 31921 31929
71. Freed E. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation Science 265 5179 1994 1713 1716
72. Irie K. Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase Science 265 5179 1994 1716 1719
73. Fu H. Interaction of the protein kinase Raf-1 with 14-3-3 proteins Science 266 5182 1994 126 129 [see comments]
74. Shimizu K. Synergistic activation by Ras and 14-3-3 protein of a mitogen-activated protein kinase named Ras-dependent extracellular signal-regulated kinase stimulator J Biol Chem 269 37 1994 22917 22920
75. Fantl W.J. Activation of Raf-1 by 14-3-3 proteins Nature 371 6498 1994 612 614
76. Busino L. Degradation of Cdc25A by beta-TrCP during S-phase and in response to DNA damage Nature 426 6962 2003 87 91
77. Chang H.C., and Rubin G.M. 14-3-3Epsilon positively regulates Ras-mediated signaling in Drosophila Genes Dev 11 9 1997 1132 1139
78. Kockel L. Requirement for Drosophila 14-3-3zeta in Raf-dependent photoreceptor development Genes Dev 11 9 1997 1140 1147
79. Yip-Schneider M.T. Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association Biochem J 351 Pt 1 2000 151 159
80. Thorson J.A. 14-3-3 Proteins are required for maintenance of Raf-1 phosphorylation and kinase activity Mol Cell Biol 18 9 1998 5229 5238
81. Roy S. 14-3-3 Facilitates Ras-dependent Raf-1 activation in vitro and in vivo Mol Cell Biol 18 7 1998 3947 3955
82. McPherson R.A. Interactions of c-Raf-1 with phosphatidylserine and 14-3-3 Oncogene 18 26 1999 3862 3869
83. Li S. Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins EMBO J 14 4 1995 685 696
84. Dumaz N., and Marais R. Protein kinase A blocks Raf-1 activity by stimulating 14-3-3-binding and blocking Raf-1 interaction with Ras J Biol Chem 278 32 2003 29819 29823
85. Light Y., Paterson H., and Marais R. 14-3-3 Antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity Mol Cell Biol 22 14 2002 4984 4996
86. Michaud N.R. 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3- and Ras- independent manner Mol Cell Biol 15 6 1995 3390 3397
87. Ory S. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3-binding sites Curr Biol 13 2003 1 20
88. Jaumot M., and Hancock J.F. Protein phosphatases 1and 2A promote Raf-1 activation by regulating 14-3-3 interactions Oncogene 20 30 2001 3949 3958
89. Van Der Hoeven P.C. 14-3-3 Isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation Biochem J 345 Pt 2 2000 297 306
90. Blomberg I., and Hoffmann I. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases Mol Cell Biol 19 9 1999 6183 6194
91. Sexl V. A rate limiting function of cdc25A for S-phase entry inversely correlates with tyrosine dephosphorylation of Cdk2 Oncogene 18 3 1999 573 582
92. Molinari M. Human Cdc25 A inactivation in response to S-phase inhibition and its role in preventing premature mitosis EMBO Rep 1 1 2000 71 79
93. Bernardi R., Liebermann D.A., and Hoffman B. Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation Oncogene 19 20 2000 2447 2454
94. Millar J.B. p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells Proc Natl Acad Sci USA 88 23 1991 10500 10504
95. Donzelli M., and Draetta G.F. Regulating mammalian checkpoints through Cdc25 inactivation EMBO Rep 4 7 2003 671 677
96. Chen M.S., Ryan C.E., and Piwnica-Worms H. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3-binding Mol Cell Biol 23 21 2003 7488 7497
97. Forrest A., and Gabrielli B. Cdc25B activity is regulated by 14-3-3 Oncogene 20 32 2001 4393 4401
98. Booher R., and Beach D. Involvement of a type 1protein phosphatase encoded by bws1+ in fission yeast mitotic control Cell 57 6 1989 1009 1016
99. Liu F. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14and localizes to the endoplasmic reticulum and Golgi complex Mol Cell Biol 17 2 1997 571 583
100. Lundgren K. Mik1 and Wee1 cooperate in the inhibitory tyrosine phosphorylation of Cdc2 Cell 64 6 1991 1111 1122
101. Parker L.L. Phosphorylation and inactivation of the mitotic inhibitor Wee1 by the nim1/cdr1 kinase Nature 363 6431 1993 736 738
102. Dalal S.N. Cytoplasmic localization of human Cdc25C during interphase requires an intact 14-3-3-binding site Mol Cell Biol 19 6 1999 4465 4479
103. Lopez-Girona A. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein Nature 397 6715 1999 172 175
104. Kumagai A., and Dunphy W.G. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25 Genes Dev 13 9 1999 1067 1072
105. Yang J. Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import EMBO J 18 8 1999 2174 2183
106. Zeng Y., and Piwnica-Worms H. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3-binding Mol Cell Biol 19 11 1999 7410 7419
107. Graves P.R. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding Oncogene 20 15 2001 1839 1851
108. Sanchez Y. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25 Science 277 5331 1997 1497 1501 [see comments]
109. Raleigh J.M., and O'Connell M.J. The G(2) DNA damage checkpoint targets both Wee1 and Cdc25 J Cell Sci 113 Pt 10 2000 1727 1736
110. Peng C.Y. C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216and promotes 14-3-3 protein binding Cell Growth Differ 9 3 1998 197 208
111. Zeng Y. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1 Nature 395 6701 1998 507 510
112. Matsuoka S., Huang M., and Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase Science 282 5395 1998 1893 1897
113. Furnari B., Rhind N., and Russell P. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase Science 277 5331 1997 1495 1497
114. Zhao H., Watkins J.L., and Piwnica-Worms H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints Proc Natl Acad Sci USA 99 23 2002 14795 14800
115. Margolis S.S. PP1 control of M-phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation EMBO J 22 21 2003 5734 5745
116. Bulavin D.V. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry Nat Cell Biol 5 6 2003 545 551
117. Mailand N. Rapid destruction of human Cdc25A in response to DNA damage Science 288 5470 2000 1425 1429
118. Shimuta K. Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition EMBO J 21 14 2002 3694 3703
119. Jin J. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase Genes Dev 17 24 2003 3062 3074
120. Chen M.S., Ryan C.E., and Piwnica-Worms H. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3-binding Mol Cell Biol 23 21 2003 7488 7497
121. Ridley A.J. Cell migration: integrating signals from front to back Science 302 5651 2003 1704 1709
122. Danen E.H., and Sonnenberg A. Integrins in regulation of tissue development and function J Pathol 201 4 2003 632 641
123. Bogenrieder T., and Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis Oncogene 22 42 2003 6524 6536
124. Han D.C., Rodriguez L.G., and Guan J.L. Identification of a novel interaction between integrin beta1 and 14-3-3beta Oncogene 20 3 2001 346 357
125. Fagerholm S. Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes J Biol Chem 277 3 2002 1728 1738 [Epub 2001 Nov 7]
126. Santoro M.M., Gaudino G., and Marchisio P.C. The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration Dev Cell 5 2 2003 257 271
127. Garcia-Guzman M. Cell adhesion regulates the interaction between the docking protein p130(Cas) and the 14-3-3 proteins J Biol Chem 274 9 1999 5762 5768
128. Baxter H.C. Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain Neuroscience 109 1 2002 5 14
129. Fountoulakis M., Cairns N., and Lubec G. Increased levels of 14-3-3gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome J Neural Transm Suppl 57 1999 323 335
130. Kato M., and Dobyns W.B. Lissencephaly and the molecular basis of neuronal migration Hum Mol Genet 12 2003 R89 R96
131. Peyrl A. Aberrant expression of signaling-related proteins 14-3-3gamma and RACK1 in fetal Down syndrome brain (trisomy 21) Electrophoresis 23 1 2002 152 157
132. Berg D., Holzmann C., and Riess O. 14-3-3 Proteins in the nervous system Nat Rev Neurosci 4 9 2003 752 762
133. Hashiguchi M., Sobue K., and Paudel H.K. 14-3-3Zeta is an effector of Tau protein phosphorylation J Biol Chem 275 33 2000 25247 25254
134. Layfield R. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins Neurosci Lett 209 1 1996 57 60
135. Paudel H.K. Phosphorylation by neuronal Cdc2-like protein kinase promotes dimerization of Tau protein in vitro J Biol Chem 272 45 1997 28328 28334
136. Agarwal-Mawal A. 14-3-3 Connects glycogen synthase kinase-3beta to Tau within a brain microtubule-associated Tau phosphorylation complex J Biol Chem 278 15 2003 12722 12728
137. Cardoso C. Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, MillerDieker syndrome, and other phenotypes secondary to deletions of 17p13.3 Am J Hum Genet 72 4 2003 918 930 [Epub 2003 Mar 5]
138. + channel activity EMBO J 21 2002 1889 1898
139. Xing H. 14-3-3 Proteins block apoptosis and differentially regulate MAPK cascades EMBO J 19 2000 349 358
140. Bae S. Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart Am J Physiol 285 2003 H983 H990